Cryptochromes Interact Directly with PIFs to Control Plant Growth in Limiting Blue Light | Cell | 2016 | 295 |
Integrin-based therapeutics: biological basis, clinical use and new drugs | Nature Reviews Drug Discovery | 2016 | 239 |
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity | Blood | 2016 | 222 |
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis | JAMA Oncology | 2016 | 190 |
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors | JAMA Oncology | 2016 | 141 |
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors | Journal of Translational Medicine | 2016 | 113 |
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial | JAMA Oncology | 2016 | 89 |
B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients | Clinical Cancer Research | 2016 | 83 |
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group | Annals of Surgical Oncology | 2016 | 82 |
Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial | Journal of Clinical Endocrinology and Metabolism | 2016 | 77 |
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy | Npj Genomic Medicine | 2016 | 74 |
Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF) | PLoS ONE | 2016 | 73 |
Effects of marital status and economic resources on survival after cancer: A population-based study | Cancer | 2016 | 70 |
Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images | PLoS ONE | 2016 | 60 |
Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid | Cancer Biomarkers | 2016 | 57 |
3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice | Nature Medicine | 2016 | 54 |
Leveraging premalignant biology for immune-based cancer prevention | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 44 |
Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study | American Journal of Clinical Oncology: Cancer Clinical Trials | 2016 | 44 |
Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice | Arteriosclerosis, Thrombosis, and Vascular Biology | 2016 | 42 |
miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3 | Cancer Research | 2016 | 39 |
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria | Annals of Surgery | 2016 | 38 |
Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma | Molecular Cancer Therapeutics | 2016 | 38 |
Urokinase-controlled tumor penetrating peptide | Journal of Controlled Release | 2016 | 36 |
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine | BMC Cancer | 2016 | 33 |
Population-Based Epidemiology and Mortality of Small Malignant Gastrointestinal Stromal Tumors in the USA | Journal of Gastrointestinal Surgery | 2016 | 32 |